phase 1_initiation
saveBio-Innova Co Ltd — dapagliflozin (Phase I Trial Initiation)
community read0 votes
Therapy area: Cardiovascular, Genito Urinary System, Metabolic Disorders. Indication: Cardiovascular Risk Factors, Diabetic Nephropathy, Type 1 Diabetes (Juvenile Diabetes), Type 2 Diabetes
Data sources
globaldata
Found something off?
drug timeline · 8
- approvalDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE) — FDA approvalApr 6, 2026 · 184d ago
- approvalDAPAGLIFLOZIN — FDA approvalApr 6, 2026 · 184d ago
- approvalDAPAGLIFLOZIN — FDA approvalApr 6, 2026 · 184d ago
- approvalDAPAGLIFLOZIN — FDA approvalApr 6, 2026 · 184d ago
- approvalDAPAGLIFLOZIN — FDA approvalApr 6, 2026 · 184d ago
- approvalDAPAGLIFLOZIN — FDA approvalApr 6, 2026 · 184d ago
- approvalDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalApr 6, 2026 · 184d ago
- approvalDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalApr 6, 2026 · 184d ago
same company · ±60 days · 2
🐶 often sniffed alongside
top 8- tagApproval78 co-mentions · 27 sources
- drugDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE65 co-mentions · 29 sources
- drugDAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE65 co-mentions · 29 sources
- tagSmall Molecule37 co-mentions · 26 sources
- drugmetformin22 co-mentions · 10 sources
- drugSITAGLIPTIN AND METFORMIN HYDROCHLORIDE22 co-mentions · 10 sources
- drugmetformin hydrochloride22 co-mentions · 10 sources
- drugmetformin hydrochloride ER22 co-mentions · 10 sources
comments(0)
5-min edit window · permanent after that